ProfileGDS4718 / 202992_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 58% 53% 95% 47% 73% 27% 35% 52% 67% 57% 61% 64% 29% 21% 28% 70% 75% 28% 32% 28% 60% 65% 69% 74% 68% 20% 74% 20% 65% 37% 35% 61% 50% 29% 51% 38% 24% 68% 52% 91% 65% 30% 64% 40% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0119958
GSM549102patient 115, normal, homogenized [OPG study]5.6927253
GSM549104patient 119, normal, homogenized [OPG study]10.329595
GSM549108patient 138, normal, homogenized [OPG study]5.4027947
GSM549119patient 077, normal, homogenized [OPG study]7.059273
GSM549133patient 032, cancer, homogenized [OPG study]4.3654327
GSM549139patient 042, cancer, homogenized [OPG study]4.7280635
GSM549099patient 107, normal, homogenized [OPG study]5.6458952
GSM549109patient 139, normal, homogenized [OPG study]6.6194567
GSM549110patient 046, normal, homogenized [OPG study]5.9532557
GSM549114patient 063, normal, homogenized [OPG study]6.1177361
GSM549122patient 082, normal, homogenized [OPG study]6.4373464
GSM549134patient 033, cancer, homogenized [OPG study]4.4898829
GSM549136patient 036, cancer, homogenized [OPG study]4.1398821
GSM549140patient 044, cancer, homogenized [OPG study]4.4042428
GSM549111patient 047, normal, homogenized [OPG study]6.8819670
GSM549113patient 057, normal, homogenized [OPG study]7.3545975
GSM549132patient 031, cancer, homogenized [OPG study]4.4634428
GSM549137patient 038, cancer, homogenized [OPG study]4.6114232
GSM549142patient 047, cancer, homogenized [OPG study]4.5528828
GSM549100patient 110, normal, homogenized [OPG study]6.0892760
GSM549107patient 135, normal, homogenized [OPG study]6.4360365
GSM549115patient 068, normal, homogenized [OPG study]6.8078569
GSM549116patient 072, normal, homogenized [OPG study]7.2232974
GSM549120patient 078, normal, homogenized [OPG study]6.7001768
GSM549131patient 030, cancer, homogenized [OPG study]4.0858520
GSM549118patient 074, normal, homogenized [OPG study]7.2262874
GSM549129patient 027, cancer, homogenized [OPG study]4.1699520
GSM549123patient 088, normal, homogenized [OPG study]6.4579865
GSM549124patient 006, cancer, homogenized [OPG study]4.8734237
GSM549126patient 015, cancer, homogenized [OPG study]4.7556635
GSM549128patient 025, cancer, homogenized [OPG study]6.2231661
GSM549103patient 117, normal, homogenized [OPG study]5.5857750
GSM549117patient 073, normal, homogenized [OPG study]4.4952829
GSM549138patient 041, cancer, homogenized [OPG study]5.5629351
GSM549141patient 045, cancer, homogenized [OPG study]4.8318138
GSM549130patient 028, cancer, homogenized [OPG study]4.314324
GSM549101patient 111, normal, homogenized [OPG study]6.7038668
GSM549105patient 128, normal, homogenized [OPG study]5.6509552
GSM549106patient 134, normal, homogenized [OPG study]9.45291
GSM549112patient 048, normal, homogenized [OPG study]6.4989165
GSM549125patient 011, cancer, homogenized [OPG study]4.5400530
GSM549127patient 024, cancer, homogenized [OPG study]6.4801564
GSM549135patient 035, cancer, homogenized [OPG study]4.9161740